Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Researchers discover RAF oncogene that may drive aggressive forms of prostate cancer

Researchers discover RAF oncogene that may drive aggressive forms of prostate cancer

Progenics presents Phase 1 PSMA ADC therapy study data for taxane-refractory prostate cancer at ASCO 2010

Progenics presents Phase 1 PSMA ADC therapy study data for taxane-refractory prostate cancer at ASCO 2010

GTx presents quality of life results from Ostarine Phase IIb study in cancer cachexia patients at ASCO 2010

GTx presents quality of life results from Ostarine Phase IIb study in cancer cachexia patients at ASCO 2010

Threshold Pharmaceuticals presents results of TH-302 Phase 1/2 trials in solid tumors at ASCO

Threshold Pharmaceuticals presents results of TH-302 Phase 1/2 trials in solid tumors at ASCO

Chronix' DNA blood tests detect prostate, breast cancer with 92% sensitivity and 100% specificity

Chronix' DNA blood tests detect prostate, breast cancer with 92% sensitivity and 100% specificity

Final results from Phase 1 trial of OGX-427 for treating solid tumors presented at ASCO 2010

Final results from Phase 1 trial of OGX-427 for treating solid tumors presented at ASCO 2010

Genetic mutations help predict risk of prostate cancer in younger men: Researchers

Genetic mutations help predict risk of prostate cancer in younger men: Researchers

CytRx granted U.S. Patent for bafetinib

CytRx granted U.S. Patent for bafetinib

Harbor BioSciences to raise $2.06M through sale of common stock shares and warrants

Harbor BioSciences to raise $2.06M through sale of common stock shares and warrants

BioSante's GVAX CML Vaccine granted FDA Orphan Drug designation

BioSante's GVAX CML Vaccine granted FDA Orphan Drug designation

Chronix's serum DNA assays have potential to detect early stage breast cancer, prostate cancer

Chronix's serum DNA assays have potential to detect early stage breast cancer, prostate cancer

Phase 3 trial demonstrates superiority of Amgen's denosumab over Zometa in preventing SREs

Phase 3 trial demonstrates superiority of Amgen's denosumab over Zometa in preventing SREs

Selenium not beneficial in reducing risk of lung cancer development

Selenium not beneficial in reducing risk of lung cancer development

New molecular imaging agent improves diagnosis of recurrent prostate cancer

New molecular imaging agent improves diagnosis of recurrent prostate cancer

Positive results from new analyses of denosumab Phase 3 trials

Positive results from new analyses of denosumab Phase 3 trials

Bayer to present Phase I and II clinical trial data of Alpharadin in CRPC at 46th ASCO

Bayer to present Phase I and II clinical trial data of Alpharadin in CRPC at 46th ASCO

Light therapy may be alternative treatment for prostate cancer

Light therapy may be alternative treatment for prostate cancer

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Protox Therapeutics reports positive data from Phase 2b study of PRX302 in BPH

Protox Therapeutics reports positive data from Phase 2b study of PRX302 in BPH

Researchers develop new technique to detect cathepsin K in atherosclerosis, cancer metastasis

Researchers develop new technique to detect cathepsin K in atherosclerosis, cancer metastasis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.